Physician profile
Joseph Golden
NPI 1518496850
$5,094.30
in general payments reported to CMS, 2019-2025
31 companies · $2,028 in 2025
The $2,028 reported for 2025 was more than what 84% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $13.35 · 2021: $165 · 2022: $643 · 2023: $1,169 · 2024: $1,076 · 2025: $2,028.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,273.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,273.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,241.03 | 2023-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $570.38 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $465.66 | 2023-2025 | Ekosonic, Bodyguardian, Opticross 35 |
| Shockwave Medical, INC | $334.13 | 2025 | |
| Medtronic, INC. | $294.14 | 2022-2025 | Corevalve Evolut R, Symplicity G3 |
| Kestra Medical Technology Services, INC. | $249.12 | 2024-2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $185.89 | 2021-2025 | Verquvo, Bridion |
| Amgen INC. | $178.99 | 2023-2025 | Repatha, Repatha |
| Sanofi-Aventis U.S. LLC | $166.26 | 2021-2024 | |
| Stryker Corporation | $166.08 | 2025 | Artix Mt, Clottriever Bold Catheter, Ct Thrombectomy System Kit |
| Inari Medical, INC. | $157.47 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Itamar Medical INC | $153.58 | 2025 | Watchpatone |
| Actelion Pharmaceuticals US, INC. | $125.00 | 2023 | Uptravi, Opsumit |
| Abbott Laboratories | $110.30 | 2022-2025 | Diamondback Coronary |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.11 | 2021-2024 | Jardiance |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $91.27 | 2021-2025 | Farxiga |
| Chiesi USA, INC. | $72.00 | 2023 | Kengreal |
| Pfizer INC. | $56.66 | 2021-2025 | |
| Novo Nordisk INC | $51.14 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Penumbra, INC. | $48.00 | 2023 | Indigo System |
| Bayer Healthcare Pharmaceuticals INC. | $44.26 | 2025 | |
| E.R. Squibb & Sons, L.L.C. | $40.48 | 2021-2023 | Camzyos |
| Inspire Medical Systems, INC. | $40.26 | 2025 | Inspire |
| Irhythm Technologies, INC. | $25.32 | 2024 | Zio Xt Patch, Zio Monitor |
| Zoll Circulation INC | $24.81 | 2023 | Downstream Cartridge, Catheter, Therox Ds2 Console |
| Kiniksa Pharmaceuticals International, Plc | $23.48 | 2024 | Arcalyst |
| Lilly USA, LLC | $20.13 | 2025 | Mounjaro |
| Ambu INC. | $19.52 | 2024 | |
| Philips North America LLC | $14.58 | 2025 | Ecc Solutions |
| Bard Peripheral Vascular, INC. | $13.90 | 2024 | Lutonix Drug Coated Balloon |
| Janssen Pharmaceuticals, INC | $13.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Golden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.